Cresco Labs (CRLBF) Accumulated Expenses (2020 - 2026)

Cresco Labs has reported Accumulated Expenses for 7 years, with the latest figure at $55.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 1.98% year-over-year to $55.0 million; the trailing twelve-month figure through Mar 2026 stood at $55.0 million (down 1.98% YoY), and the FY2025 full-year result was $58.0 million, up 6.85% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $55.0 million, down from $58.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $96.0 million in Q1 2022, with the low at $45.9 million in Q2 2022.
• Historically, Accumulated Expenses has averaged $59.6 million across 5 years, with a median of $56.1 million in 2025.
• Annual changes were most pronounced in 2024 — Accumulated Expenses fell 21.4% — and 2025, when it climbed 6.85%.
• Cresco Labs' Accumulated Expenses stood at $58.6 million in 2022, then advanced by 17.9% to $69.1 million in 2023, then retreated by 21.4% to $54.3 million in 2024, then climbed by 6.85% to $58.0 million in 2025, then fell by 5.14% to $55.0 million in 2026.
• The last three Accumulated Expenses figures came in at $55.0 million (Q1 2026), $58.0 million (Q4 2025), and $50.1 million (Q3 2025), per Business Quant data.